loading page

Primary Effusion Lymphoma in a patient with a Good Outcome Despite the Lack of Chemotherapy
  • +3
  • Ofir Koren,
  • Ariel Aviv ,
  • Moran Avraham Kelbert ,
  • Ehud Rozner ,
  • Liza Lihtman ,
  • Yoav Turgeman
Ofir Koren
Emek Medical Center
Author Profile
Ariel Aviv
Emek Medical Center
Author Profile
Moran Avraham Kelbert
Emek Medical Center
Author Profile
Ehud Rozner
Emek Medical Center
Author Profile
Liza Lihtman
Emek Medical Center
Author Profile
Yoav Turgeman
Emek Medical Center
Author Profile

Abstract

Background Primary effusion lymphoma (PEL) is a rare disease occurs mostly in immunosuppressed young males. Treatment consists of chemotherapy and prognosis is poor. Case presentation Our case described immunocompetent elderly woman with PEL who survive 30 months without chemotherapy. Conclusion Physicians should be aware of all clinical scenarios of PEL

Peer review status:ACCEPTED

27 Oct 2020Submitted to Clinical Case Reports
28 Oct 2020Submission Checks Completed
28 Oct 2020Assigned to Editor
05 Nov 2020Reviewer(s) Assigned
28 Dec 2020Review(s) Completed, Editorial Evaluation Pending
17 Jan 2021Editorial Decision: Revise Minor
18 Jan 20211st Revision Received
19 Jan 2021Submission Checks Completed
19 Jan 2021Assigned to Editor
19 Jan 2021Review(s) Completed, Editorial Evaluation Pending
26 Jan 2021Editorial Decision: Revise Minor
29 Jan 20212nd Revision Received
01 Feb 2021Submission Checks Completed
01 Feb 2021Assigned to Editor
01 Feb 2021Review(s) Completed, Editorial Evaluation Pending
22 Feb 2021Editorial Decision: Accept